Literature DB >> 1955780

Hepatobiliary injury associated with experimental small-bowel bacterial overgrowth in rats.

S N Lichtman1, R B Sartor.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1955780     DOI： 10.1007/bf02919752

Source DB:  PubMed          Journal:  Immunol Res        ISSN： 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  10 in total

1.  Small intestine bacterial overgrowth.

Authors:  C E King; P P Toskes
Journal:  Gastroenterology       Date:  1979-05       Impact factor: 22.682

Review 2.  Small bowel bacterial overgrowth syndrome.

Authors:  P Sherman; S Lichtman
Journal:  Dig Dis       Date:  1987       Impact factor: 2.404

3.  Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome.

Authors:  S L Welkos; P P Toskes; H Baer
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

4.  Biliary tract disease in rats with experimental small bowel bacterial overgrowth.

Authors:  S N Lichtman; J Keku; R L Clark; J H Schwab; R B Sartor
Journal:  Hepatology       Date:  1991-04       Impact factor: 17.425

5.  Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth.

Authors:  S N Lichtman; R B Sartor; J Keku; J H Schwab
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

7.  Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

8.  Treatment of experimental erosive arthritis in rats by injection of the muralytic enzyme mutanolysin.

Authors:  M J Janusz; C Chetty; R A Eisenberg; W J Cromartie; J H Schwab
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

9.  Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis.

Authors:  S M Wahl; D A Hunt; J B Allen; R L Wilder; L Paglia; A R Hand
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307
  10 in total
  6 in total

Review 1.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

Review 2.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

Review 3.  Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management.

Authors:  John E Eaton; Jayant A Talwalkar; Konstantinos N Lazaridis; Gregory J Gores; Keith D Lindor
Journal:  Gastroenterology       Date:  2013-07-01       Impact factor: 22.682

Review 4.  Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?

Authors:  Katharina Brandl; Bernd Schnabl
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-06-18       Impact factor: 3.869

Review 5.  Animal models in primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Peter Fickert
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 6.  Pathogenesis of primary sclerosing cholangitis.

Authors:  Marion J Pollheimer; Emina Halilbasic; Peter Fickert; Michael Trauner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-12       Impact factor: 3.043
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.